文献速递心脏核医学

18F-氟脱氧葡萄糖心肌缺血记忆显像对疑似不稳定型心绞痛患者主要不良心血管事件的增量预后价值

Incremental prognostic value of 18F-fluorodeoxyglucose myocardial ischemic memory imaging for major adverse cardiovascular events in patients with suspected unstable angina.
PubMed 文献 · J Nucl Cardiol · 2024-10-04

该研究为前瞻性研究的事后分析,纳入265例疑似不稳定型心绞痛患者,评估18F-FDG PET心肌缺血记忆显像在临床危险因素、GRACE评分和冠状动脉钙化积分之外的增量预后价值。中位随访25个月,51例(19.2%)发生主要不良心血管事件;18F-FDG阳性、标准化摄取比及范围均为独立预测因子,加入18F-FDG PET显像后风险分层显著改善。

要点

  • 在疑似不稳定型心绞痛患者中,18F-FDG PET阳性是主要不良心血管事件的独立预测因子(HR=3.220)。
  • 18F-FDG PET显像加入临床因素、GRACE评分和CACS后,C指数由.688提升至.769(P=.045)。
  • 净重分类改善为.324(P=.020),综合判别改善为.055(P=.027)。

核心结论

  • 18F-FDG PET心肌缺血记忆显像显著改善疑似不稳定型心绞痛患者的预后评估,在临床危险因素、GRACE评分和CACS之外提供有价值的额外风险分层。

研究设计与样本

  • 本研究为前瞻性研究的事后分析,纳入265例疑似不稳定型心绞痛患者(男性62.3%,平均年龄65.0±9.4岁)。
  • 18F-FDG阳性定义为局灶或局灶伴弥漫摄取模式;主要不良心血管事件包括心血管死亡、急性心肌梗死、心力衰竭、因不稳定型心绞痛再住院和卒中。

主要发现

  • 中位随访25个月,51例患者(19.2%)发生主要不良心血管事件。
  • 18F-FDG阳性(HR=3.220,95%CI:1.630-6.360,P<.001)、18F-FDG标准化摄取比(HR=1.330,95%CI:1.131-1.564,P=.0006)和范围(HR=1.045,95%CI:1.028-1.062,P<.0001)均为主要不良心血管事件的独立预测因子。
  • 加入18F-FDG PET显像后,风险分层较临床因素、GRACE评分和CACS显著改善,C指数由.688提升至.769(P=.045),NRI为.324(P=.020),IDI为.055(P=.027)。

关键数值与推荐

  • 18F-FDG阳性定义为局灶或局灶伴弥漫摄取模式。
  • 主要不良心血管事件包括心血管死亡、急性心肌梗死、心力衰竭、因不稳定型心绞痛再住院和卒中。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The additional prognostic value of 18F-flurodeoxyglucose positron emission tomography (18F-FDG PET) myocardial ischemic memory imaging for patients with suspected unstable angina (UA) is not well established. This study aimed to determine whether 18F-FDG PET imaging provides incremental prognostic information for predicting major adverse cardiac events (MACEs) compared to clinical risk factors, Global Registry of Acute Coronary Events (GRACE) score, and coronary artery calcium score (CACS) in patients with suspected UA. METHODS: In this post hoc analysis of a prospective study, 265 patients suspected with UA (62.3% male, mean age: 65.0±9.4 years) were enrolled. 18F-FDG positivity was defined as focal or focal on diffuse uptake patterns. MACEs included cardiovascular death, acute myocardial infarction, heart failure, rehospitalization for UA, and stroke. Multivariable Cox regression was used to identify predictors of MACEs, and the incremental prognostic value of 18F-FDG PET imaging was assessed using the Concordance Index (C-index), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). RESULTS: Over a median follow-up of 25 months, 51 patients (19.2%) experienced MACEs. 18F-FDG positivity (hazard ratio [HR]=3.220, 95% confidence interval [CI]: 1.630-6.360, P<.001), as well as 18F-FDG standardized uptake ratio (HR=1.330, 95% CI: 1.131-1.564, P=.0006) and Extent (HR=1.045, 95% CI: 1.028-1.062, P<.0001), were independent predictors of MACE. The addition of 18F-FDG PET imaging significantly improved risk stratification beyond clinical factors, the GRACE score, and CACS, with improved C-index (.769 vs .688, P=.045), NRI (.324, P=.020), and IDI (.055, P=.027). CONCLUSION: 18F-FDG PET myocardial ischemic memory imaging significantly improves prognostic assessment for patients with suspected UA, providing valuable additional risk stratification beyond clinical risk factors, GRACE score, and CACS.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Zhang F, Yang X, Chen Y, et al. Incremental prognostic value of 18F-fluorodeoxyglucose myocardial ischemic memory imaging for major adverse cardiovascular events in patients with suspected unstable angina. J Nucl Cardiol. 2024. PMID: 39368661. doi:10.1016/j.nuclcard.2024.102051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。